Ke Zheng
-
- Cancer, Hypoxia, and Metabolism 5
- Cancer, Lipids, and Metabolism 2
-
- RNA modifications and cancer 3
- Metabolism, Diabetes, and Cancer 2
-
- Clusterin in disease pathology 2
-
- Cervical Cancer and HPV Research 4
-
- Genital Health and Disease 2
- Pancreatic function and diabetes 2
- Co-authors
- Yuhui JiangChunmin MaTao ChenQin ZhaoJohn DoorbarHeather GriffinNagayasu EgawaWenhua Huang
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Ke Zheng
18 papers receiving 272 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 76
- Molecular Biology 160
- Oncology 58
- Epidemiology 69
- Immunology 35
Countries citing papers authored by Ke Zheng
This map shows the geographic impact of Ke Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Zheng more than expected).
Fields of papers citing papers by Ke Zheng
This network shows the impact of papers produced by Ke Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Zheng. The network helps show where Ke Zheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ke Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 26 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 22 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 47 | |
| 12 | 2019 | 37 | |
| 13 | 2019 | 26 | |
| 14 | 2015 | 17 | |
| 15 | 2015 | 1 | |
| 16 | [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma]. | 2006 | 2 |
| 17 | [Correlation of clusterin expression to prognosis of bladder carcinoma]. | 2005 | 1 |
| 18 | [Characteristics of neoplasm occurrence of renal allograft recipients and their prognosis]. | 2005 | 3 |
About Ke Zheng
Ke Zheng is a scholar working on Cancer Research, Transplantation, Virology, Urology and Oncology, having authored 18 papers that have together received 275 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cervical Cancer and HPV Research (4 papers), RNA modifications and cancer (3 papers), Cancer, Lipids, and Metabolism (2 papers), Genital Health and Disease (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Pancreatic function and diabetes (2 papers) and Clusterin in disease pathology (2 papers). The work is most often cited by research in Cancer Research (76 citations), Molecular Biology (160 citations), Oncology (58 citations), Epidemiology (69 citations) and Immunology (35 citations). Ke Zheng has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Yuhui Jiang, Chunmin Ma, Tao Chen, Qin Zhao, John Doorbar, Heather Griffin, Nagayasu Egawa, Wenhua Huang, Jingjie Li and Wang Wang. Their work appears in journals such as Cancer Research, iScience, PLoS Pathogens, Cellular Oncology and Current Opinion in Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.